Commerzbank Aktiengesellschaft’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.87M | Sell |
39,227
-32,834
| -46% | -$7.06M | 0.2% | 62 |
|
|
2026
Q1 | $15.7M | Sell |
72,061
-7,351
| -9% | -$1.63M | 0.33% | 45 |
|
|
2025
Q4 | $18.1M | Sell |
79,412
-10,690
| -12% | -$2.44M | 0.37% | 42 |
|
|
2025
Q3 | $20.9M | Sell |
90,102
-39,586
| -31% | -$8.06M | 0.43% | 42 |
|
|
2025
Q2 | $24.1M | Buy |
129,688
+70,418
| +119% | +$13.1M | 0.55% | 37 |
|
|
2025
Q1 | $12.4M | Buy |
59,270
+2,786
| +5% | +$542K | 0.29% | 47 |
|
|
2024
Q4 | $9.95M | Buy |
56,484
+19,291
| +52% | +$3.55M | 0.24% | 50 |
|
|
2024
Q3 | $7.34M | Buy |
37,193
+22,425
| +152% | +$4.19M | 0.2% | 57 |
|
|
2024
Q2 | $2.53M | Buy |
14,768
+4,451
| +43% | +$737K | 0.08% | 81 |
|
|
2024
Q1 | $1.88M | Buy |
10,317
+1,542
| +18% | +$266K | 0.06% | 82 |
|
|
2023
Q4 | $1.36M | Buy |
8,775
+6,048
| +222% | +$882K | 0.05% | 74 |
|
|
2023
Q3 | $406K | Buy |
+2,727
| New | +$400K | 0.02% | 102 |
|
|
2022
Q4 | – | Sell |
-5,936
| Closed | -$797K | – | 128 |
|
|
2022
Q3 | $797K | Buy |
+5,936
| New | +$852K | 0.06% | 67 |
|
|
2020
Q2 | – | Sell |
-26,210
| Closed | -$2M | – | 102 |
|
|
2020
Q1 | $2M | Sell |
26,210
-503,767
| -95% | -$42.9M | 0.09% | 115 |
|
|
2019
Q4 | $46.9M | Sell |
529,977
-114,348
| -18% | -$9.49M | 0.46% | 43 |
|
|
2019
Q3 | $48.8M | Buy |
644,325
+149,303
| +30% | +$10.2M | 0.37% | 58 |
|
|
2019
Q2 | $36M | Buy |
495,022
+207,922
| +72% | +$16.3M | 0.28% | 74 |
|
|
2019
Q1 | $23.1M | Buy |
287,100
+78,440
| +38% | +$6.42M | 0.21% | 95 |
|
|
2018
Q4 | $19.2M | Buy |
208,660
+29,816
| +17% | +$2.62M | 0.2% | 94 |
|
|
2018
Q3 | $16.9M | Sell |
178,844
-69,762
| -28% | -$6.62M | 0.15% | 122 |
|
|
2018
Q2 | $23M | Buy |
248,606
+16,664
| +7% | +$1.63M | 0.22% | 94 |
|
|
2018
Q1 | $22M | Buy |
231,942
+155,475
| +203% | +$17.1M | 0.23% | 92 |
|
|
2017
Q4 | $7.39M | Buy |
76,467
+41,057
| +116% | +$3.87M | 0.08% | 202 |
|
|
2017
Q3 | $3.15M | Buy |
35,410
+17,049
| +93% | +$1.3M | 0.04% | 303 |
|
|
2017
Q2 | $1.33M | Sell |
18,361
-51,885
| -74% | -$3.49M | 0.02% | 376 |
|
|
2017
Q1 | $4.58M | Buy |
70,246
+6,097
| +10% | +$383K | 0.07% | 232 |
|
|
2016
Q4 | $4.02M | Buy |
64,149
+18,715
| +41% | +$1.14M | 0.06% | 244 |
|
|
2016
Q3 | $2.87M | Sell |
45,434
-187,002
| -80% | -$12.1M | 0.05% | 280 |
|
|
2016
Q2 | $14.4K | Buy |
232,436
+154,679
| +199% | +$9.43M | 0.1% | 119 |
|
|
2016
Q1 | $4.44M | Sell |
77,757
-323,796
| -81% | -$18M | 0.04% | 254 |
|
|
2015
Q4 | $23.8M | Buy |
401,553
+271,393
| +209% | +$15.6M | 0.18% | 101 |
|
|
2015
Q3 | $7.08M | Sell |
130,160
-113,170
| -47% | -$7.37M | 0.05% | 216 |
|
|
2015
Q2 | $16.3M | Buy |
243,330
+28,933
| +13% | +$1.89M | 0.09% | 155 |
|
|
2015
Q1 | $12.6M | Sell |
214,397
-18,133
| -8% | -$1.1M | 0.08% | 192 |
|
|
2014
Q4 | $15.2M | Sell |
232,530
-266,813
| -53% | -$16.8M | 0.1% | 179 |
|
|
2014
Q3 | $28.8M | Buy |
499,343
+92,067
| +23% | +$5.11M | 0.12% | 136 |
|
|
2014
Q2 | $23M | Sell |
407,276
-34,869
| -8% | -$1.83M | 0.12% | 139 |
|
|
2014
Q1 | $22.7M | Sell |
442,145
-89,762
| -17% | -$4.54M | 0.1% | 136 |
|
|
2013
Q4 | $26.2M | Sell |
531,907
-125,318
| -19% | -$6.16M | 0.13% | 117 |
|
|
2013
Q3 | $29.4M | Sell |
657,225
-858,221
| -57% | -$38M | 0.15% | 130 |
|
|
2013
Q2 | $62.6M | Buy |
+1,515,446
| New | +$66.3M | 0.28% | 70 |
|
Other funds holding ABBV
Commerzbank Aktiengesellschaft's ABBV Position: Q2 2026 in Review
Commerzbank Aktiengesellschaft reduced its AbbVie (ABBV) stake by 46% in Q2 2026, selling an estimated $7.06M and leaving 39,227 shares worth $9.87M. The position accounts for 0.2% of the portfolio, ranked #62.
Commerzbank Aktiengesellschaft first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. The position peaked at $62.6M in Q2 2013. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Commerzbank Aktiengesellschaft held 39,227 shares of AbbVie worth $9.87M as of Q2 2026.
- Commerzbank Aktiengesellschaft sold 32,834 AbbVie shares in Q2 2026, an estimated $7.06M.
- AbbVie made up 0.2% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #62 holding.
- Commerzbank Aktiengesellschaft first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
- Commerzbank Aktiengesellschaft's AbbVie position peaked at $62.6M in Q2 2013.
- 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.